Pramipexole ER vs. Placebo in Fibromyalgia

PHASE2TerminatedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2008

Conditions
Fibromyalgia
Interventions
DRUG

pramipexole ER

DRUG

placebo

Trial Locations (42)

Unknown

248.637.01009 Boehringer Ingelheim Investigational Site, Birmingham

248.637.01033 Boehringer Ingelheim Investigational Site, Phoenix

248.637.01045 Boehringer Ingelheim Investigational Site, Tucson

248.637.01034 Boehringer Ingelheim Investigational Site, Hot Springs

248.637.01032 Boehringer Ingelheim Investigational Site, Arcadia

248.637.01044 Boehringer Ingelheim Investigational Site, Los Angeles

248.637.01036 Boehringer Ingelheim Investigational Site, Santa Ana

248.637.01042 Boehringer Ingelheim Investigational Site, Englewood

248.637.01031 Boehringer Ingelheim Investigational Site, Danbury

248.637.01035 Boehringer Ingelheim Investigational Site, DeLand

248.637.01023 Boehringer Ingelheim Investigational Site, Fort Myers

248.637.01047 Boehringer Ingelheim Investigational Site, Orlando

248.637.01043 Boehringer Ingelheim Investigational Site, Palm Beach Gardens

248.637.01040 Boehringer Ingelheim Investigational Site, Sunrise

248.637.01027 Boehringer Ingelheim Investigational Site, Tampa

248.637.01007 Boehringer Ingelheim Investigational Site, Atlanta

248.637.01028 Boehringer Ingelheim Investigational Site, Chicago

248.637.01010 Boehringer Ingelheim Investigational Site, Lexington

248.637.01016 Boehringer Ingelheim Investigational Site, Newton

248.637.01014 Boehringer Ingelheim Investigational Site, Lansing

248.637.01020 Boehringer Ingelheim Investigational Site, Flowood

248.637.01018 Boehringer Ingelheim Investigational Site, Picayune

248.637.01012 Boehringer Ingelheim Investigational Site, Kansas City

248.637.01017 Boehringer Ingelheim Investigational Site, Billings

248.637.01024 Boehringer Ingelheim Investigational Site, Albuquerque

248.637.01008 Boehringer Ingelheim Investigational Site, Albany

248.637.01002 Boehringer Ingelheim Investigational Site, New York

248.637.01025 Boehringer Ingelheim Investigational Site, Charlotte

248.637.01026 Boehringer Ingelheim Investigational Site, Fargo

248.637.01004 Boehringer Ingelheim Investigational Site, Cincinnati

248.637.01038 Boehringer Ingelheim Investigational Site, Columbus

248.637.01003 Boehringer Ingelheim Investigational Site, Oklahoma City

248.637.01046 Boehringer Ingelheim Investigational Site, Medford

248.637.01006 Boehringer Ingelheim Investigational Site, Portland

248.637.01039 Boehringer Ingelheim Investigational Site, Duncansville

248.637.01015 Boehringer Ingelheim Investigational Site, Warwick

248.637.01019 Boehringer Ingelheim Investigational Site, Austin

248.637.01037 Boehringer Ingelheim Investigational Site, San Antonio

248.637.01041 Boehringer Ingelheim Investigational Site, Salt Lake City

248.637.01021 Boehringer Ingelheim Investigational Site, Renton

248.637.01029 Boehringer Ingelheim Investigational Site, Seattle

248.637.01011 Boehringer Ingelheim Investigational Site, Spokane

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY